IDEXX Laboratories Inc. (IDXX)
IDXX · Health Care · 
United States
IDEXX Laboratories Inc. (IDXX) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.67%. Anyone who holds an ETF containing IDEXX Laboratories also has an indirect stake in the company.
Data and Charts: IDEXX Laboratories
Key Data for IDEXX Laboratories
IDEXX Laboratories Stock Price Chart
The IDEXX Laboratories chart shows daily closing prices and is set to the current year by default. The stock is down 18.5% year to date and down 12.3% over twelve months. The last recorded close on October 30, 2026, was $551.21, at 18% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
IDEXX Laboratories Stock Performance
| Year to date | -18.5% | 1 year | -12.3% |
|---|---|---|---|
| 1 month | +5.6% | 3 months | -1.4% |
| Calendar year 2025 | +63.6% |
Measured in euros, IDEXX Laboratories is down 14.3% year to date and down 9.3% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: IDEXX Laboratories
IDEXX Laboratories Connections
The map shows how IDEXX Laboratories connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation.
- United States Country · domicile
- XUHL ETF · holds
- XUHC ETF · holds
- Health Care Sector · sector
- GE Healthcare Technologies Stock · similar ETF exposure
- Gilead Sciences Stock · similar ETF exposure
- Vertex Pharmaceuticals Incorporated Stock · similar ETF exposure
What ETF Is IDEXX Laboratories In?
IDEXX Laboratories has very high ETF coverage and is held by 25 of the 104 ETFs we track, which together follow 12 indices. That puts the stock in more ETFs than 92.5% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.67% | €6.74 |
| XDWH | MSCI World Health Care | 0.50% | €5.02 |
| SPFS | MSCI World Health Care | 0.50% | €5.01 |
| XDEW | S&P 500 Equal Weight | 0.22% | €2.18 |
| 2B7K | MSCI World SRI | 0.21% | €2.10 |
| EXXT | Nasdaq 100 | 0.20% | €2.00 |
| XNAS / XNA1 | Nasdaq 100 | 0.20% | €1.96 |
| XDEQ | MSCI World Quality | 0.16% | €1.58 |
| SXR8 | S&P 500 | 0.07% | €0.70 |
| XD9U / XD9D | MSCI USA | 0.07% | €0.68 |
| SPYL / SPY5 | S&P 500 | 0.07% | €0.68 |
| EUNL | MSCI World | 0.05% | €0.50 |
| IUSQ | MSCI ACWI | 0.05% | €0.50 |
| XDWD / XDWL | MSCI World | 0.05% | €0.50 |
| SWWD | MSCI World | 0.05% | €0.49 |
| SPPW | MSCI World | 0.05% | €0.49 |
| SPYI / SPSA | MSCI ACWI IMI | 0.05% | €0.48 |
| WIMI | MSCI World IMI | 0.05% | €0.45 |
| SPYY | MSCI ACWI | 0.04% | €0.42 |
The last column shows how much of €1,000 in one of these funds goes to IDEXX Laboratories, based on each fund's latest holdings list.
US-listed ETFs holding IDEXX Laboratories (weight per latest SEC filing): QQQM 0.19%, QQQ 0.18%, VUG 0.13%, ONEQ 0.09%, IVV 0.06%, SPY 0.06%, VOO 0.06%, VTI 0.06%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
IDEXX Laboratories Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), IDEXX Laboratories had a weight of 0.06% on Sep 30, 2019 and 0.05% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.09% on Jun 30, 2021. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much IDEXX Laboratories overlaps with the rest of a portfolio.
Which Tracked Investors Hold IDEXX Laboratories?
IDEXX Laboratories is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds IDEXX Laboratories increased its position.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 33,528 | $18M | increased by 23,214 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to IDEXX Laboratories
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| IDEXX Laboratories | – | – | -12.3% | 36.6% | 24.6% | +10.4% |
 Vertex Pharmaceuticals Incorporated | 25 | – | +33.1% | 31.8% | 32.9% | +8.9% |
 DexCom | 24 | – | +20.7% | 40.8% | 17.9% | +15.6% |
 Gilead Sciences | 25 | – | +44.1% | 26.8% | 28.9% | +2.4% |
 Intuitive Surgical | 23 | – | -18.5% | 34.2% | 28.4% | +20.5% |
 Amgen | 24 | – | +59.6% | 27.7% | 21.0% | +10.0% |
 Regeneron Pharmaceuticals | 23 | – | +41.9% | 36.5% | 31.4% | +1.0% |
 Waters Corporation | 22 | – | +34.9% | 37.1% | 20.3% | +7.0% |
| Zoetis | 22 | +0.61 | -44.7% | 31.4% | 28.2% | +2.3% |
These stocks reach a portfolio through largely the same funds as IDEXX Laboratories. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: IDEXX Laboratories
IDEXX Laboratories Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 3.7 | 0.8 | 23.1% |
| FY ended Dec 2024 | 3.9 | 0.9 | 22.8% |
| FY ended Dec 2025 | 4.3 | 1.1 | 24.6% |
Technical Analysis: IDEXX Laboratories
IDEXX Laboratories Risk Metrics
The close on Oct 30, 2026, was 28.1% below the highest close since Aug 12, 2024. That high was reached on Nov 25, 2025. When the S&P 500 rose or fell 1%, IDEXX Laboratories moved 0.80% on average in the same direction (past 252 trading days). The correlation of 0.32, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of IDEXX Laboratories.
What IDEXX Laboratories Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| STERIS plc | +0.67 | |
| ResMed Inc. | +0.64 | |
| Stryker Corporation | +0.64 | |
| Medtronic Plc | +0.62 | |
| Zoetis Inc. Class A | +0.61 | |
| Zimmer Biomet Holdings Inc. | +0.60 | |
| Nebius Group N.V. Class A | -0.41 | |
| Hewlett Packard Enterprise Co. | -0.39 | |
| Teradyne Inc. | -0.38 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
